drugset / Trial / NCT03062774

Continuous Multiple Dose PB-119 Injection in Health Volunteers

NCT03062774

Phase 1 Completed 36 enrolled PegBio Co., Ltd.
SequentialOpen-labelTreatment

Summary

This is an open label, multiple dose study, pharmacokinetic and pharmacodynamics studies will be performed at the same time with tolerability study. Three dose arms are designed, 12 subjects will be enrolled in each arm, will equal number of males and females.

Timeline

Start
2014-11-15
Primary completion
2016-09-13
Completion
2016-10-08

Drugs

EvaluationDrugModalityDoseRoute
Subject PB-119 Peptide 25 ug Subcutaneous
Subject PB-119 Peptide 50 ug Subcutaneous
Subject PB-119 Peptide 100 ug Subcutaneous